Target intelligence / Profile preview

SEC14-like lipid binding protein 4 (SEC14L4)

Target
SEC14L4
Molecular classification
Lipid binding protein, Phosphatidylinositol transfer protein (PITP), Peripheral membrane protein, SEC14 domain-containing protein
01

Overview

SEC14-like lipid binding protein 4 (SEC14L4) is a member of the SEC14 superfamily, characterized by a lipid-binding SEC14 domain capable of transporting and exchanging small lipophilic molecules, such as phospholipids and other hydrophobic substrates, between intracellular membranes. SEC14L4 and related proteins are essential regulators of membrane identity, vesicular trafficking, and phosphoinositide metabolism and signaling in eukaryotic cells. By functioning as phosphatidylinositol transfer proteins (PITPs), SEC14-like proteins facilitate diverse cellular processes, including signal transduction, adaptation to environmental stimuli, cell division, and organismal development. Mutations in SEC14 superfamily members have been implicated in cancer, neurodegeneration, and developmental disorders, underscoring their biological and therapeutic significance. No direct therapeutic agents targeting SEC14L4 have been developed, but ongoing research in lipid signaling pathways may yield future modulators or inhibitors.

Other names
SEC14L4SEC14-like phosphatidylinositol transfer protein 4S14L4 protein
02

Mechanism of action

Drugs targeting SEC14 domain proteins typically modulate lipid transport or exchange, thus affecting phosphoinositide signaling and membrane trafficking. Potential future mechanisms may include inhibition or enhancement of lipid-transfer activity.

03

Biological functions

Membrane traffickingLipid transport and exchangeRegulation of phosphoinositide metabolismSignal transductionMaintenance of membrane identity
04

Disease associations

Cancer (mutations in SEC14-like proteins are associated with increased cancer risk)Neurodegenerative diseases (mutations implicated in pathogenesis)Possibly other conditions related to defects in lipid signaling and membrane trafficking (e.g., developmental defects)
05

Safety considerations

As SEC14 domain proteins are involved in fundamental cellular processes (membrane trafficking, lipid signaling), therapeutic modulation could cause off-target effects affecting cell viability or tissue homeostasisSpecific safety concerns for SEC14L4 remain unreported due to lack of clinical therapeutics targeting it

Beyond the preview

Go deeper on SEC14-like lipid binding protein 4 (SEC14L4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SEC14-like lipid binding protein 4 (SEC14L4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call